Details for New Drug Application (NDA): 089120

✉ Email this page to a colleague

NDA 089120 describes PHENTERMINE RESIN 30, which is a drug marketed by Quantum Pharmics and is included in one NDA. Additional details are available on the PHENTERMINE RESIN 30 profile page.

The generic ingredient in PHENTERMINE RESIN 30 is phentermine resin complex. There are seventeen drug master file entries for this compound. Additional details are available on the phentermine resin complex profile page.

Summary for 089120

Tradename:	PHENTERMINE RESIN 30
Applicant:	Quantum Pharmics
Ingredient:	phentermine resin complex
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	CAPSULE, EXTENDED RELEASE;ORAL			Strength	EQ 30MG BASE
Approval Date:	Feb 4, 1988	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.